BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3985926)

  • 1. PY 108-068, a dihydropyridine derivative, and verapamil interact differently with the ouabain effects on the heart and the peripheral circulation.
    Hof RP; Hof A
    Basic Res Cardiol; 1985; 80(1):66-75. PubMed ID: 3985926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The calcium antagonists PY 108-068 and verapamil diminish the effects of angiotensin II: sites of interaction in the peripheral circulation of anaesthetized cats.
    Hof RP
    Br J Pharmacol; 1984 May; 82(1):51-60. PubMed ID: 6733358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of vasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits.
    Hof RP
    Br J Pharmacol; 1985 May; 85(1):75-87. PubMed ID: 4027474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem.
    Hof RP
    Br J Pharmacol; 1983 Feb; 78(2):375-94. PubMed ID: 6831117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PY 108-068: a calcium antagonist with an unusual pattern of cardiovascular activity.
    Hof RP
    Gen Pharmacol; 1985; 16(1):1-6. PubMed ID: 2579873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the vasoconstrictor effects of noradrenaline and serotonin by the selective calcium antagonist PY 108-068 in the peripheral circulation of anesthetized cats.
    Hof RP; Hof A; Kalkman HO
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S53-60. PubMed ID: 2414596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PY 108-068, a new calcium antagonist, on general hemodynamics and regional blood flow in anesthetized cats: a comparison with nifedipine.
    Hof RP; Hof A; Neumann P
    J Cardiovasc Pharmacol; 1982; 4(3):352-62. PubMed ID: 6177929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutual inhibition and synergistic effects of ergotamine and the calcium antagonist darodipine.
    Hof RP; Hof A
    Gen Pharmacol; 1986; 17(3):309-14. PubMed ID: 3721185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.
    Duncker DJ; Hartog JM; Hugenholtz PG; Saxena PR; Verdouw PD
    Br J Pharmacol; 1986 May; 88(1):9-18. PubMed ID: 2871886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
    Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of verapamil, nifedipine and flunarizine on haemodynamics and regional blood flows in pentobarbitone-anaesthetized rats.
    Waite RP; Pang CC; Walker MJ
    J Pharm Pharmacol; 1990 May; 42(5):325-31. PubMed ID: 1976779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1984; 6(5):881-7. PubMed ID: 6209495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
    Sassen LM; Soei LK; Koning MM; Verdouw PD
    Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.
    Soward AL; Vanhaleweyk GL; Serruys PW
    Drugs; 1986 Jul; 32(1):66-101. PubMed ID: 2874975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the calcium antagonist PY 108-068 on myocardial tissues in vitro and on reflex tachycardia in vivo.
    Hof RP; Scholtysik G
    J Cardiovasc Pharmacol; 1983; 5(2):176-83. PubMed ID: 6188886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs.
    Hof RP; Hof A; Scholtysik G; Menninger K
    J Cardiovasc Pharmacol; 1984; 6(3):407-16. PubMed ID: 6202965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antagonistic effects of ouabain and calcium channel blockers on the contractility of the isolated rat heart.
    Favereau X; Dunica S; Chevallier B; Mouas C; Swynghedauw B
    J Pharmacol; 1986; 17(4):651-6. PubMed ID: 3560974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem.
    Quartaroli M; Gambini F; Tarter G; Micheli D; Trist DG; Gaviraghi G
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):326-36. PubMed ID: 1720831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.